New drug trial aims to stop liver cancer from coming back after treatment
Disease control
Recruiting now
This study is testing whether adding a PD-1 inhibitor drug after microwave ablation treatment can help prevent early-stage liver cancer from returning. Researchers want to see if this combination approach improves how long patients live without their cancer coming back. The study…
Phase: NA • Sponsor: Chen Xiaoping • Aim: Disease control
Last updated Apr 01, 2026 22:41 UTC